SinoFresh HealthCare Teams Up With National Starch and Chemical Company, Targets New Product Launch for 2008
Posted on: Monday, 29 October 2007, 12:00 CDT
SinoFresh HealthCare, Inc. (OTCBB: SFSH) announced today that it has entered into a non-binding Letter-of-Intent with National Starch and Chemical Company to develop new and improved versions of popular allergy-related OTC medicines. The Company is targeting the new formulations to be launched in March 2008 in time for the spring and summer allergy season.
The new products are expected to have a number of advantages over current products available, including new ingredients that help to alleviate allergy symptoms at a much quicker rate, ease-of-use features that fit on-the-go lifestyles, and easier to follow patient instructions.
The first new product by SinoFresh seeks to eliminate symptoms such as sneezing, runny nose and itchy, watery eyes. The second product targets the relief of sinus pressure and nasal congestion. Both products utilize National Starch's proprietary patented PROLOC(TM) bio-adhesive technology to deliver the drug formulations.
Until now, SinoFresh has typically focused on the Chronic Sinusitis market. SinoFresh believes entering the allergy market with new and improved patent protected products adds significant market advantages to SinoFresh according to Charles Fust, CEO, SinoFresh HealthCare, Inc. "In the United States, our current nasal spray has been aimed at helping the 37 million people who suffer from Chronic Sinusitis. By developing new and improved allergy-related formulations, we expect to help an additional 50 million people who suffer from allergies. We believe an alliance with National Starch and Chemical makes it possible for us to capitalize on this enormous opportunity," said Fust.
Bill Wilferth, Chief Operating Officer, stated, "We listened to a lot of consumer feedback from allergy sufferers and incorporated that marketing data into an updated research strategy for new products that we feel will make an impact with both retail outlets and consumers."
Michael Trisch, Global Business Manager for National Starch and Chemical Company, states, "We look forward to working with SinoFresh and establishing our new PROLOC(TM) bio-adhesive technology in the allergy segment."
About National Starch and Chemical Company
National Starch and Chemical Company, a member of the ICI Group, is a worldwide manufacturer of natural polymers, specialty polymers, adhesives, and electronic materials, with 2006 sales of $3.7 billion. National Starch is headquartered in Bridgewater, N.J. For more information about National Starch and Chemical Company, visit www.nationalstarch.com.
About SinoFresh HealthCare, Inc.
SinoFresh HealthCare, Inc. (OTCBB: SFSH) is a developer and marketer of innovative upper respiratory system therapies. The company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms that are suspected to cause pathogenesis of the mouth, nose and throat. The company's lead product, SinoFresh(TM) Nasal and Sinus Care is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The company is also researching how antiseptic cleansing may alleviate chronic sinus distress, a condition that may affect 37 million Americans annually. SinoFresh(TM) products are available in Rite Aid, CVS, Duane Reade and other drug, grocery and mass merchandise retailers. More information is available at www.sinofresh.com.
Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements speak only as of the date on which such statements are made and involve risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, including risks summarized in the Company's Annual Report on Form 10-KSB for its fiscal year ended December 31, 2006, (file No. 0-49764). The Company's actual results could differ materially from such forward-looking statements. The company undertakes no obligation to update any forward-looking statement or statements to reflect new events or circumstances or future developments. Adjusted EBITDA is not a measure of performance calculated in accordance with accounting principles generally accepted in the United States, or "GAAP."
Contacts: SinoFresh Charles Fust 941-681-3109 Parallel Marketing Services 407-517-4835 sinofresh@pms-marketing.com
SOURCE: SinoFresh HealthCare, Inc.
Source: MARKET WIRE
Related Articles
- Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
- National Media Coverage Propels Relaxation Beverage drank Forward on Consumer Stage
- Velcera Receives FDA Feedback on Innovative Canine Allergy Product
- Healthcare Liaison Launches Nation's First Accreditation Program for Private Healthcare Advocates - October 27-28
- Houston-Based CAT Introduces New North American Production Chemicals Study
- Generex Biotechnology Announces Launch of Two OTC Products at Leading Healthcare Industry Event
- Cobalis Reports All Patient Diaries in Phase III Clinical Trials for OTC Anti-Allergy Product Candidate Are Completed
- Cargill, MGP Ingredients, National Starch and Penford Settle High-Amylose Patent Litigation
- USDC and National Starch & Chemical Co. Contract Yields Commercially Viable OLED Sealing Adhesives
 |
 |
User Comments (0)
RSS Feeds